A national study involving a UT Southwestern Medical Center neonatologist and pediatric infectious diseases specialist suggests that a screening test routinely performed in newborns is not very good ...

June 1, 2011 — Real-time polymerase chain reaction (PCR) assays of both liquid- and dried-saliva specimens are highly sensitive and specific for detecting cytomegalovirus (CMV) and should be ...

When we found out we were expecting our third child, we were overjoyed. No pregnancy is easy, of course, and we already had our hands full with two little ones. But this was our third time around, and ...

COBAS AmpliPrep/COBAS TaqMan CMV Test Kit by Roche Roche announced that it has received approval from the FDA for COBAS AmpliPrep/COBAS TaqMan CMV Test, a new test to assess a patient's viral load of ...

The FDA approved the first in vitro diagnostic test used to monitor cytomegalovirus treatment in hematopoietic stem cell transplant recipients, according to a press release. With this approval, the ...

COBAS AmpliPrep/COBAS TaqMan CMV Test Kit by Roche Roche announced the commercial availability of a new test to assess a patient's viral load of cytomegalovirus (CMV). Roche announced the commercial ...

Laura Gibson is an associate professor of medicine and of pediatrics at UMass Chan Medical School. CMV belongs to the same virus family as cold sores and chickenpox and, like those viruses, lives in ...

(Reuters) Jun 05 - U.S. health regulators on Thursday approved a first-of-its-kind DNA test by Swiss drugmaker Roche Holding AG to help physicians track progress in treating organ transplant patients ...

The FDA has granted premarket approval to a test that assesses a patient’s viral load of cytomegalovirus (CMV), the most common and important viral infection in recipients of solid organ transplants.

First FDA-approved laboratory test for quantifying DNA of potentially deadly virus helps physicians manage organ transplant patients on antiviral therapy "With this new test, diagnostic laboratories ...

(Reuters) - U.S. health regulators on Thursday approved a first-of-its-kind DNA test by Swiss drugmaker Roche Holding AG to help physicians track progress in treating organ transplant patients for a ...